Angiotensin II-induced cardiovascular load regulates cardiac remodeling and related gene expression in late-gestation fetal sheep

Pediatric Research

Volumn 75, Issue 6, 2014, Pages 689-696

  Norris, Andrew W ^a   Bahr, Timothy M ^a   Scholz, Thomas D ^a   Peterson, Emily S ^a   Volk, Ken A ^a   Segar, Jeffrey L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENALAPRILAT; INTERLEUKIN 6; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; CARBON DIOXIDE TENSION; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; EWE; EXPERIMENTAL SHEEP; FEMALE; FETUS; FETUS HEART; FETUS HEART RATE; FETUS WEIGHT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE; HEART SIZE; HEART WEIGHT; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; THIRD TRIMESTER PREGNANCY; TWIN PREGNANCY; ANALYSIS OF VARIANCE; ANIMAL; CARDIOVASCULAR FUNCTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; PREGNANCY; SHEEP;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; CELL PROLIFERATION; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOBLOTTING; LOSARTAN; MICROARRAY ANALYSIS; MYOCYTES, CARDIAC; PREGNANCY; SHEEP; VENTRICULAR REMODELING;

EID: 84900872345     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2014.37     Document Type: Article

References (38)

1. Barry SP, Davidson SM, Townsend PA. Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 2008;40:2023-39.
2. Tornburg K, Jonker S, O'Tierney P, et al. Regulation of the cardiomyocyte population in the developing heart. Prog Biophys Mol Biol 2011;106:289-99.
3. Jonker SS, Faber JJ, Anderson DF, Tornburg KL, Louey S, Giraud GD. Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension. Am J Physiol Regul Integr Comp Physiol 2007;292:R913-9.
4. Schlüter KD, Wenzel S. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hyper-trophic cross-talks. Pharmacol Ter 2008;119:311-25.
5. Segar JL, Dalshaug GB, Bedell KA, Smith OM, Scholz TD. Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep. Am J Physiol Regul Integr Comp Physiol 2001;281:R2037-47.
6. O'Tierney PF, Anderson DF, Faber JJ, Louey S, Tornburg KL, Giraud GD. Reduced systolic pressure load decreases cell-cycle activity in the fetal sheep heart. Am J Physiol Regul Integr Comp Physiol 2010;299: R573-8.
7. Jonker SS, Zhang L, Louey S, Giraud GD, Tornburg KL, Faber JJ. Myocyte enlargement, diferentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol (1985) 2007;102:1130-42.
8. Barbera A, Giraud GD, Reller MD, Maylie J, Morton MJ, Tornburg KL. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am J Physiol Regul Integr Comp Physiol 2000;279:R1157-64.
9. Montgomery MO, Jiao Y, Phillips SJ, et al. Alterations in sheep fetal right ventricular tissue with induced hemodynamic pressure overload. Basic Res Cardiol 1998;93:192-200.
10. Olson AK, Protheroe KN, Scholz TD, Segar JL. The mitogen-activated protein kinases and Akt are developmentally regulated in the chronically anemic fetal sheep heart. J Soc Gynecol Investig 2006;13:157-65.
11. Braz JC, Bueno OF, Liang Q, et al. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 2003;111:1475-86.
12. Liao P, Georgakopoulos D, Kovacs A, et al. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 2001;98:12283-8.
13. Kato N, Liang YQ, Ochiai Y, Birukawa N, Serizawa M, Jesmin S. Candesar-tan-induced gene expression in fve organs of stroke-prone spontaneously hypertensive rats. Hypertens Res 2008;31:1963-75.
14. Brooks W W, Bing OH, Conrad CH, et al. Captopril modifes gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats. Hypertension 1997;30:1362-8.
15. Jin H, Yang R, Awad TA, et al. Efects of early angiotensin-converting enzyme inhibition on cardiac gene expression afer acute myocardial infarction. Circulation 2001;103:736-42.
16. Kang BY, Hu C, Ryu S, et al. Genomics of cardiac remodeling in angio-tensin II-treated wild-type and LOX-1-defcient mice. Physiol Genomics 2010;42:42-54.
17. Montana ES, Littleton JT. Expression profling of a hypercontraction- induced myopathy in Drosophila suggests a compensatory cytoskeletal remodeling response. J Biol Chem 2006;281:8100-9.
18. Hu C, Dandapat A, Sun L, et al. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 2008;52:556-62.
19. Koitabashi N, Danner T, Zaiman AL, et al. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011;121:2301-12.
20. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 2004;63:423-32.
21. Smeets PJ, Teunissen BE, Planavila A, et al. Infammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxi-some proliferator-activated receptors PPARalpha and PPARdelta. J Biol Chem 2008;283:29109-18.
22. Valente AJ, Clark RA, Siddesha JM, Siebenlist U, Chandrasekar B. CIKS (Act1 or TRAF3IP2) mediates angiotensin-II-induced interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy. J Mol Cell Cardiol 2012;53:113-24.
23. del Vescovo CD, Cotecchia S, Diviani D. A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy. Mol Cell Biol 2013;33:14-27.
24. Papay RS, Shi T, Piascik MT, Naga Prasad S V, Perez DM. αA-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion. Mol Pharmacol 2013;83:939-48.
25. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental fndings and therapeutic strategies. Pharmacol Ter 2010;128: 191-227.
26. Brüel A, Christofersen TE, Nyengaard JR. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc Res 2007;76:400-8.
27. Tseng YT, Yano N, Rojan A, et al. Ontogeny of phosphoinositide 3-kinase signaling in developing heart: efect of acute beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 2005;289:H1834-42.
28. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 2000;62:289-319.
29. Sundgren NC, Giraud GD, Schultz JM, Lasarev MR, Stork PJ, Torn-burg KL. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol 2003;285:R1481-9.
30. Goyal R, Longo LD. Gene expression in sheep carotid arteries: major changes with maturational development. Pediatr Res 2012;72:137-46.
31. Altschul SF, Gish W, Miller W, Myers E W, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
32. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2005;33(Database issue):D54-8.
33. Wheeler DL, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2007;35(Data-base issue):D5-12.
34. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open sofware development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
35. Silver JD, Ritchie ME, Smyth GK. Microarray background correction: maximum likelihood estimation for the normal-exponential convolution. Biostatistics 2009;10:352-63.
36. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York, NY: Springer, 2005:397-420.
37. Johnson WE, Li C, Rabinovic A. Adjusting batch efects in microarray expression data using empirical Bayes methods. Biostatistics 2007;8:118-27.
38. Storey JD. A direct approach to false discovery rates. J R Stat Soc 2002;64:479-98.